INTERNATIONAL PATENT: REGOR PHARMACEUTICALS, INC. FILES APPLICATION FOR "SALT AND SOLID FORMS OF A HPK1 INHIBITOR"

GENEVA, July 3 -- REGOR PHARMACEUTICALS, INC. (245 Main Street, Second FloorCambridge, MA) filed a patent application (PCT/US2024/060859) for "SALT AND SOLID FORMS OF A HPK1 INHIBITOR" on Dec 18, 2024. With publication no. WO/2025/137168, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FENG, Song (c/o Qilu Regor Therapeutics Inc.Building 10, No. 1206, Zhangjiang RoadShanghai, 201210), ZHONG, Wenge (c/o Regor Pharmaceuticals, Inc.245 Main Street, Second FloorCambridge, MA 02142), ZHU, Xiaotian (c/o Regor Pharmaceuticals, I...